These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24064760)
1. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Li Y; Zhu W; Li J; Liu M; Wei M Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits phosphorylation within the signal transduction and activator of transcription 3 signaling pathway by activating sirtuin 1 in SW1353 chondrosarcoma cells. Jin H; Chen H; Yu K; Zhang J; Li B; Cai N; Pan J Mol Med Rep; 2016 Sep; 14(3):2685-90. PubMed ID: 27484919 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Parekh P; Motiwale L; Naik N; Rao KV Exp Toxicol Pathol; 2011 Jan; 63(1-2):167-73. PubMed ID: 20133117 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of the inhibition of the STAT3 signaling pathway by EGCG. Wang Y; Ren X; Deng C; Yang L; Yan E; Guo T; Li Y; Xu MX Oncol Rep; 2013 Dec; 30(6):2691-6. PubMed ID: 24065300 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Lu Y; Yue X; Cui Y; Zhang J; Wang K Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells. Zhang H; Yang R Hepatogastroenterology; 2014; 61(130):410-2. PubMed ID: 24901151 [TBL] [Abstract][Full Text] [Related]
7. The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress. Moghadam D; Zarei R; Vakili S; Ghojoghi R; Zarezade V; Veisi A; Sabaghan M; Azadbakht O; Behrouj H Mol Biol Rep; 2023 Jan; 50(1):77-84. PubMed ID: 36307623 [TBL] [Abstract][Full Text] [Related]
8. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway. Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Yu H; Pan C; Zhao S; Wang Z; Zhang H; Wu W Biomed Pharmacother; 2008; 62(6):366-72. PubMed ID: 17988825 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762 [TBL] [Abstract][Full Text] [Related]
11. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy. Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694 [TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768 [TBL] [Abstract][Full Text] [Related]
13. [Knockdown of STAT3 inhibits proliferation and migration of HepG2 hepatoma cells induced by IFN1]. Li X; Wang Y; Yan B; Fang P; Ma C; Xu N; Fu X; Liang S Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):115-122. PubMed ID: 29673453 [TBL] [Abstract][Full Text] [Related]
14. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway. Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro. Xu M; Wang Y; Chen L; Pan B; Chen F; Fang Y; Yu Z; Chen G Gene; 2014 Feb; 536(1):84-9. PubMed ID: 24334120 [TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits adventitial fibroblast proliferation and induces cell apoptosis through the SIRT1 pathway. Ling L; Gu S; Cheng Y Mol Med Rep; 2017 Feb; 15(2):567-572. PubMed ID: 28101569 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells. Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340 [TBL] [Abstract][Full Text] [Related]
19. [10-gingerol inhibits proliferation of hepatocellular carcinoma HepG2 cells via Src/STAT3 signaling pathway]. Chen J; Wu Y; Li S; Wu H; Li L Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):1002-1007. PubMed ID: 30187878 [TBL] [Abstract][Full Text] [Related]
20. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation. Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]